Who Paid My Doc
Biozorb
Device Breast and Skeletal Health
PDI 15420045514065
General payments
$766,282
Research payments
$1,750
Through program year 2025, $766,282 in general payments and $1,750 in research payments were reported against Biozorb (Breast and Skeletal Health).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $131,938 | 22 |
| 2024 | General | $367,115 | 126 |
| 2023 | General | $156,088 | 250 |
| 2022 | General | $58,704 | 245 |
| 2021 | General | $52,437 | 43 |
| 2021 | Research | $1,750 | 1 |
Breakdown
The top 5 of 17 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
686 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.